New references on AP

[Guest guest]

Hi All,

 

See these

 

Phil

 

Spence, D. Warren; Kayumov, Leonid; Chen, Adam; Lowe, Alan;

Jain, Umesh; Katzman, Martin A.; Shen, Jianhua; Perelman, Boris;

Shapiro, Colin M. AP Increases Nocturnal Melatonin Secretion and

Reduces Insomnia and Anxiety: A Preliminary Report. Journal of

Neuropsychiatry & Clinical Neurosciences 16 (1) 2004, 19-28.

Centre for Addiction and Mental Health, Toronto, ON, Canada;

lkayumov The response to AP of 18 anxious

adult subjects who complained of insomnia was assessed in an

open prepost clinical trial study. Five weeks of AP treatment was

associated with a significant (p=0.002) nocturnal increase in

endogenous melatonin secretion (as measured in urine) and

significant improvements in polysomnographic measures of sleep

onset latency (p=0.003), arousal index (p=0.001), total sleep time

(p=0.001), and sleep efficiency (p=0.002). Significant reductions in

state (p=0.049) and trait (p=0.004) anxiety scores were also found.

These objective findings are consistent with clinical reports of AP's

relaxant effects AP treatment may be of value for some categories

of anxious patients with insomnia. (PsycINFO Database Record ©

2004 APA, all rights reserved)

 

White Peter; Lewith George; Hopwood Val; Prescott Phil The

placebo needle, is it a valid and convincing placebo for use in AP

trials? A randomised, single-blind, cross-over pilot trial. Pain 106

(3) 2003, 401-409. Complementary Medicine Research Unit, Mail

Point OPH, Royal South Hants Hospital, University of

Southampton, Southampton, United Kingdom; Complementary

Medicine Research Unit, Mail Point OPH, Royal South Hants

Hospital, University of Southampton, Southampton, United

Kingdom; Complementary Medicine Research Unit, Mail Point

OPH, Royal South Hants Hospital, University of Southampton,

Southampton, United Kingdom; Department of Mathematics,

University of Southampton, Southampton, United Kingdom

pjw1 The issue of what constitutes an effective and

realistic AP placebo control has been a continuing problem for AP

research. In order to provide an effective placebo, the control

procedure must be convincing, visible and should mimic, in all

respects, apart from a physiological effect , the real active

treatment The 'Streitberger' needle might fulfil these criteria and this

paper reports on a validation study. This was a single-blind,

randomised, cross-over pilot study. Patients were drawn from the

orthopaedic hip and knee, joint replacement waiting list.

Intervention consisted of either 2 weeks of treatment with real AP

followed by 2 weeks on placebo, or vice versa. The prime outcome

was a needle sensation questionnaire and there was a range of

secondary outcomes. Thirty-seven patients were randomised and

completed treatment No significant differences between groups or

needle types were found for any of the sensations measured. No

major differences in outcome between real and placebo needling

could be found. The fact that nearly 40% of subjects did NOT find

that the two interventions were similar, however, raises some

concerns with regard to the wholesale adoption of this instrument

as a standard AP placebo. (PsycINFO Database Record © 2004

APA, all rights reserved)

 

 

Best regards,

 

Email: <

 

WORK : Teagasc, c/o 1 Esker Lawns, Lucan, Dublin, Ireland

Mobile: 353-; [in the Republic: 0]

 

HOME : 1 Esker Lawns, Lucan, Dublin, Ireland

Tel : 353-; [in the Republic: 0]

WWW : http://homepage.eircom.net/~progers/searchap.htm

 

Chinese Proverb: " Man who says it can't be done, should not interrupt man doing

it "